Medical Developments International Limited (ASX:MVP)
Australia flag Australia · Delayed Price · Currency is AUD
0.6400
+0.0700 (12.28%)
May 2, 2025, 4:10 PM AEST

Medical Developments International Company Description

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally.

The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures.

The company also distributes asthma and chronic obstructive pulmonary disease products, such space chambers, peak flow meters, portable nebulisers, and silicon face mask.

The company was founded in 1972 and is headquartered in Scoresby, Australia.

Medical Developments International Limited
Medical Developments International logo
Country Australia
Founded 1972
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 68
CEO Brent MacGregor

Contact Details

Address:
4 Caribbean Drive
Scoresby, 3179
Australia
Phone 61 3 9547 1888
Website medicaldev.com

Stock Details

Ticker Symbol MVP
Exchange Australian Securities Exchange
Fiscal Year July - June
Reporting Currency AUD
ISIN Number AU000000MVP2
SIC Code 2834

Key Executives

Name Position
Brent MacGregor Chief Executive Officer
Anita James Chief Financial Officer
Anastasia Tan Head of Operations and Supply Chain
Dr. Scott Courtney Chief Scientific Officer
Tara Eaton General Counsel and Company Secretary
Anthony Wheal Head of People and Culture
Wayne Pearce Head of Production
Stefaan Schatteman Head of Europe
Julianne Alexander Head of Medical Affairs and Clinical Development
Jas Singh Global Head of Respiratory